Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Labiotech.eu" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Labiotech.eu for you to read. Along with our medical data and news we also list Labiotech.eu Clinical Trials, which are updated daily. BioPortfolio also has a large database of Labiotech.eu Companies for you to search.
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become an insulin-free alternative to stop, prevent, and potentially cure this ... The post How Immunotherapy Could Stop and Prevent Type 1 Diabetes appeared first on Labiotech.eu.
A fully artificial heart, developed by the French biotech Carmat, has shown promising interim results in patients with heart failure. Ten patients in Carmat’s ongoing trial were surgically implanted with the company’s artificial heart device, which carries out the heart’s ... The post Artificial Heart Offers Hope to Heart Failure Patients appeared first on Labiotech.eu.
Hello biotechnologists, Job hunt frustrating? Don’t worry, we’re here to help. Check out the position as Research Scientist at Celyad or become a Microbiology Manager at ProClinical. Just starting out? Check out the internship at PPD! Research and Development R&D Engineer at Nouryon. ... The post Dive Deep Into a New Biotech Job! appeared first on Labiotech.eu.
“The Startup Slam provides an excellent opportunity for early stage companies to gain exposure to an international audience of potential partners and investors,” says Kari Bennett, Vice President of Marketing at EBD Group. Together with Johnson & Johnson Innovation, EBD ... The post A Startup Competition Like No Other: The Startup Slam at BIO Europe 2018! appeared first on Labiotech.eu.
Since its beginnings in the 1970s, the biotech industry has grown massively and made huge advances. At our recent Labiotech Refresh in London, Tim Haines, Managing Partner at the life science VC Abingworth, shared his views on how biotechnology has ... The post The Coming of Age of Biotechnology appeared first on Labiotech.eu.
Sanofi has signed a licensing deal with French biotech Biomunex, whose antibody technology has the potential to develop new immunotherapy treatments for cancer and infectious diseases. Sanofi will give Biomunex an upfront payment, along with further installments upon achieving key development ... The post Sanofi Obtains License for French Company’s Antibody Engineering Platform appeared first o...
Using a lab-on-a-chip device, Swiss scientists have found a way to diagnose the neurodegenerative condition Huntington’s disease from DNA in the blood in just five minutes, rather than the five hours currently required. When carrying out the diagnosis of ... The post Huntington’s Could Be Diagnosed in Five Minutes With This Lab-on-a-Chip appeared first on Labiotech.eu.
An inhaled drug from British company Verona Pharma has failed to significantly improve lung function in patients with the lung disease chronic obstructive pulmonary disease, though it did produce some benefits. The 79 patients in the phase II trial suffered ... The post Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial appeared first on Labiotech.eu.
Plastic is the staple material of modern life, and a sustainable future will need bioplastics. What is biotech doing to make this happen? “What do you include in bioplastics? Because bioplastics is a very large word,” commented Emmanuel Maille, formerly ... The post Life in Bioplastic, it’s More Fantastic appeared first on Labiotech.eu.
Update (14/01/2019): An anonymous French company on Euronext has made an offer to take over Hybrigenics Pharma. This takeover bid could be good news for Hybrigenics, which has been planning to dissolve the company after the failed Phase II trial of ... The post Update: French Biotech Considers Takeover After Failed Leukemia Drug Trial appeared first on Labiotech.eu.
Heidelberg get ready! 😍 Leading national or international scientific institutions, world-renowned hospitals, research-intensive and innovative enterprises, you can find it all in Heidelberg. Therefore, we decided to stay on our home turf, Germany, and head to Heidelberg for this one! So, you’re ... The post Next Stop: Heidelberg! 🇩🇪 appeared first on Labiotech.eu.
Small molecules have paved the way for the creation of drugs that target many of the physiological processes implicated in disease. We are continually inventing, validating and developing new drug modalities such as antibody-drug conjugates, RNA therapeutics, targeted degradation, oligonucleotides ... The post The Powerful Potential of the Biotech Industry: Unleashed through Collaboration appeared...
In the academic city of Oxford, UK, the company Arctoris is working to make life easier for cancer lab researchers, letting them ‘order’ experiments online using its robotic facilities and data analysis tools. Mission: To cut down researchers’ workloads by ... The post This Company Automates Cancer Research from Bench to Bar Charts appeared first on Labiotech.eu.
A vaccine developed by French biotech Valneva for the mosquito-borne chikungunya virus is showing big potential in a phase I study. The vaccine is a live, weakened form of the chikungunya virus. All 120 healthy volunteers taking part in the ... The post Single-Shot Vaccine for Chikungunya Virus Shows Phase I Promise appeared first on Labiotech.eu.
An electronic chip from French company Pixium Vision, inserted behind the retina to treat age-related macular degeneration, has shown excellent results in a small clinical trial. The five patients in the feasibility study suffered from dry age-related macular degeneration, the ... The post This Retinal Implant Lets Visually-Impaired Patients See Patterns appeared first on Labiotech.eu.
Scaling up is a problem a lot of biotechs find difficult, both in terms of developing from a small startup to a larger company and also in terms of manufacturing techniques and products. Ryan Cawood, CEO of Oxford Genetics is ... The post How to Scale up in Biotech appeared first on Labiotech.eu.
Haaaaaappppyyy New Year!! The new year is here and it’s time we celebrate with tons of excitement! We survived 2018 (and what a year that was) and now we’re rolling happily into 2019. The past year was pretty amazing for ... The post Happy New Year! Ready to Rock in 2019! appeared first on Labiotech.eu.
Hello biotechnologists, Job hunt frustrating? Don’t worry, we’re here to help. Check out the position as Director of R&D at 10X Genomics or become a Marketing Manager at Molecular Health. Just starting out? Check out the internship at Biomarin! Research and Development ... The post Bear With Us, We’ve Got Fresh Biotech Jobs appeared first on Labiotech.eu.
Discover recent advancements in nucleic acid therapeutics, therapeutic challenges and current on-going research to advance this field, in our latest White Paper! Click here to download. The post White Paper: The Developing Field of Nucleic Acid Therapeutics and Peptide-Based Delivery Systems appeared first on Labiotech.eu.
Discover recent advancements in nucleic acid therapeutics, therapeutic challenges and current on-going research to advance this field, in our latest White Paper! The post White Paper: Peptides and Nucleic Acid Therapeutics Dancing a Triumphant Tango appeared first on Labiotech.eu.
A gene therapy applied to the skin, developed by UK company Amryt Pharma, showed positive preclinical results for the treatment of a rare genetic skin disease. The disease, called recessive dystrophic epidermolysis bullosa (RDEB), is one of a group ... The post Topical Gene Therapy Shows Early Promise for Inherited Skin Disease appeared first on Labiotech.eu.
Many people around the world start their mornings by drinking a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a victory within a complicated field ... The post The Complications Around Patenting Biotechnology appeared first on Labiotech.eu.
Sanofi is to make an €80M equity investment in the German biotech BioNTech, and the two have agreed to co-develop a cancer vaccine based on injecting messenger RNA into solid tumors. This agreement is an extension of Sanofi and BioNTech’s collaboration, ... The post Sanofi Invests €80M in mRNA Cancer Vaccine Company appeared first on Labiotech.eu.
Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with Roche worth up to €60M. Exscientia has developed an artificial intelligence platform to boost drug discovery in pharma and biotech. “We can reduce at least ... The post AI Drug Discovery Company Raises €23M and Signs with Roche appeared first on Labiotech.eu.
SOPHiA GENETICS has completed a $77M (€67M) funding round that will expand the use of its artificial intelligence technology for genomics into hospitals across the world. The funding will mainly go towards the recruitment of new employees. The goal is ... The post Swiss Firm Raises €67M to Take Genomics AI to Hospitals appeared first on Labiotech.eu.